RET and adenocarcinoma: Key clinical features of patients with RET fusion + NSCLCs are like other fusion-driven diseases: younger age, adenocarcinoma histology, low exposure to tobacco, and with a tendency to spread to the brain (one quarter of the cases with advanced disease at the diagnosis) [28,29,30].